Dr. Himabindu Yerneni, MD

Dr. Yerneni practices at Center for Dialysis Care Westside Home Care in Rocky River, Ohio.

Dr. Yerneni's NPI, 1497063499, was assigned on September 24, 2010. Dr. Yerneni holds Ohio license 35.136622.

Dr. Yerneni's primary practice is Center for Dialysis Care Westside Home Care, at 19133 Hilliard Blvd, Rocky River, OH 44116 in Cuyahoga County. The practice phone is (440) 333-2632.

Dr. Yerneni's primary practice is Center for Dialysis Care Westside Home Care in Rocky River, Ohio. Dr. Yerneni is also affiliated with University Hospitals Cleveland Medical Center. The medical group on file is University Hospitals Medical Practices. Dmand AI also links Dr. Yerneni to 4 more hospitals and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Yerneni practices, 5 sites in all. Vendor and product names are available with a free account.

Nephrology is Dr. Yerneni's primary specialty in the NPI Registry, under taxonomy code 207RN0300X. Dr. Yerneni is licensed in Ohio.

CMS data shows 439 Medicare services from Dr. Yerneni across 5 procedure codes in 2024, for 172 Medicare patients. Medicare paid $36,162 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 172 Medicare patients who saw Dr. Yerneni in 2024. The largest group is under 65, with 77 patients. 75% of them have chronic kidney disease, and 75% have high blood pressure. 25% are also on Medicaid. Their average risk score is 4.89, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Yerneni's median patient age at 64, with 41% women.

In 2024, Dr. Yerneni wrote 2,941 Medicare Part D claims for 395 patients. 94% of them were for generic drugs. CMS names the drug for 2,714 of them, across 38 drugs with 11 or more claims each, at $606,679 in total drug cost. In 2023, CMS named 2,499 claims across 36 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 81 out of 100 for Dr. Yerneni for performance year 2024, reported as part of a group. Dr. Yerneni accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Dmand AI links 4 papers to Dr. Yerneni, published from 2012 to 2020. Dr. Yerneni has published most often in Kidney Int. Dr. Yerneni's most frequent co-authors are Praveen Kumar Gundelly, MD, Udayakumar Navaneethan, MD and Tomonori Alan Oyadomari, MD.

CMS Open Payments shows 12 general payments to Dr. Yerneni from 6 drug and device companies from 2021 to 2025. Food and beverage make up the largest share, 82% of the total. Veloxis Pharmaceuticals, Inc. paid the most, $108.